Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Piptadeniastrum africanum and Cordia plathytyrsa can increase testosterone without major metabolic changes, but may affect triglycerides and creatinine.

Topical tofacitinib is effective and safe for treating alopecia areata.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

Increasing Teneligliptin on his own caused a man's hair loss, which stopped when he ceased the medication.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

rTMS may help treat trichotillomania in some patients.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

PRP and IT are equally effective for treating localized alopecia areata, but PRP causes more pain and bleeding.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Semaglutide may worsen eating disorders in vulnerable individuals.

These new skin treatments are safer and more effective with minimal side effects.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Tofacitinib is effective and safe for treating alopecia areata.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.